Watch Ticker

Cyclacel Pharmaceuticals, Inc

Go to Cyclacel Pharmaceuticals, Inc Website

$1.51

(%)

Live

Previous Close

$1.51

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$2.0 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including C...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Cyclacel - Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program in patients with solid tumors and lymphoma -

Related tickers: CYCC, CYCCP.

Read Full Article

Cyclacel - Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 –

Related tickers: CYCC, CYCCP.

Read Full Article

Trending Tickers

DATS

XNAS

$1.24

(%)

LASE

XNAS

$2.10

(%)

NYCB

XNYS

$2.97

(%)

PACW

XNAS

$7.54

(%)

MLGO

XNAS

$0.00

(%)